Discover how the LS1 became a lightweight, swap-friendly V8 icon, from its C5 Corvette debut to HSV power upgrades, and learn ...
With FDA approval to treat marginal zone lymphoma (MZL), Bristol Myers Squibb’s Breyanzi has become the first CAR-T therapy ...
The U.S. Food and Drug Administration (FDA) has approved Breyanzi (lisocabtagene maraleucel) for the treatment of adults with relapsed or refractory marginal zone lymphoma who have received at least ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback